A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine

NCT00821483 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Frovatriptan

Sponsor

SK Chemicals Co., Ltd.